erythromycin lactobionate

出典: meddic

erythromycinerythromycin estolateerythromycin ethylsuccinateerythromycin stearateErythrosin


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/09/07 06:37:05」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.
  • Broad J, Sanger GJ.Author information Neurogastroenterology Group, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.AbstractBACKGROUND AND PURPOSE: The antibiotic azithromycin is a suggested alternative to erythromycin for treating patients with delayed gastric emptying. However, although hypothesized to activate motilin receptors, supportive evidence is unavailable. This was investigated using recombinant and naturally expressed motilin receptors in human stomach, comparing azithromycin with erythromycin.
  • British journal of pharmacology.Br J Pharmacol.2013 Apr;168(8):1859-67. doi: 10.1111/bph.12077.
  • BACKGROUND AND PURPOSE: The antibiotic azithromycin is a suggested alternative to erythromycin for treating patients with delayed gastric emptying. However, although hypothesized to activate motilin receptors, supportive evidence is unavailable. This was investigated using recombinant and naturally
  • PMID 23190027
  • Maternal-amniotic-fetal distribution of macrolide antibiotics following intravenous, intramuscular, and intraamniotic administration in late pregnant sheep.
  • Keelan JA, Nitsos I, Saito M, Musk GC, Kemp MW, Timmins M, Li S, Yaegashi N, Newnham JP.Author information School of Women's and Infants' Health, The University of Western Australia, Perth, Australia.AbstractOBJECTIVE: The objective of the study was to explore the maternal-fetal pharmacokinetics of intraamniotic (IA), intravenous (IV), or intramuscular (IM) administration of erythromycin or azithromycin in a pregnant sheep model.
  • American journal of obstetrics and gynecology.Am J Obstet Gynecol.2011 Jun;204(6):546.e10-7. doi: 10.1016/j.ajog.2011.02.035. Epub 2011 Apr 8.
  • OBJECTIVE: The objective of the study was to explore the maternal-fetal pharmacokinetics of intraamniotic (IA), intravenous (IV), or intramuscular (IM) administration of erythromycin or azithromycin in a pregnant sheep model.STUDY DESIGN: Pregnant ewes of 115-121 days' gestation received a single ma
  • PMID 21481833
  • Effect of intravenous erythromycin on the colonic motility of children and young adults during colonic manometry.
  • Dranove J, Horn D, Reddy SN, Croffie J.Author information Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN 46202, USA. jason.dranove@carolinashealthcare.orgAbstractPURPOSE: Erythromycin is successfully used as a gastroduodenal prokinetic agent. Given the limited available treatments for colonic dysmotility, further investigation into erythromycin's effect on colonic motility is warranted. We aimed to study the effect of erythromycin on colonic motility in pediatric patients with recalcitrant chronic constipation/encopresis and other suspected colonic motility disorders.
  • Journal of pediatric surgery.J Pediatr Surg.2010 Apr;45(4):777-83. doi: 10.1016/j.jpedsurg.2009.07.039.
  • PURPOSE: Erythromycin is successfully used as a gastroduodenal prokinetic agent. Given the limited available treatments for colonic dysmotility, further investigation into erythromycin's effect on colonic motility is warranted. We aimed to study the effect of erythromycin on colonic motility in pedi
  • PMID 20385286

和文文献

  • 吸入療法における抗生剤の安定性
  • 村瀬 勢津子,竹内 尚子,吉山 友二,朝長 文弥
  • 病院薬学 12(3), 241-252, 1986-06-20
  • … In this study, following commercially available injections were used : benzylpenicillin potassium (PC-G), Polymyxin B sulfate (PL), oxytetracycline (OTC), erythromycin lactobionate (EML), lincomycin hydrochloride (LCM) and amphotericin B (AMPH). …
  • NAID 110001798224

関連リンク

erythromycin [ĕ-rith″ro-mi´sin] a broad-spectrum antibiotic produced by a strain of Streptomyces erythreus, administered orally, parenterally, and topically to the skin or to the eye, and effective against a wide variety of organisms ...
Buy Erythromycin lactobionate (CAS 3847-29-8), a product for proteomics research applications, from Santa Cruz. MF: C37H67NO13.C12H22O12, MW: 1092.220 ... CAS 番号: 3847-29-8 純度: 615u/mg 分子量: 1092.220

関連画像

 « Erythromycin Lactobionate - I.VErythromycin lactobionateErythromycin Lactobionate of 3847-29-8 (Erythromycin lactobionateErythromycin LactobionateErythromycin Lactobionate


★リンクテーブル★
リンク元Erythrosin」「erythromycin stearate」「ラクトビオン酸エリスロマイシン」「エリスロマイシンラクトビオン酸塩
関連記事erythromycin

Erythrosin」

  [★]

エリスロシン

erythromycinerythromycin estolateerythromycin ethylsuccinateerythromycin lactobionateerythromycin stearateerythrosinerythrosine

erythromycin stearate」

  [★] ステアリン酸エリスロマイシン

erythromycinerythromycin estolateerythromycin ethylsuccinateerythromycin lactobionateErythrosin


ラクトビオン酸エリスロマイシン」

  [★]

erythromycin lactobionate
エリスロマイシンエリスロマイシンラクトビオン酸塩


エリスロマイシンラクトビオン酸塩」

  [★]

erythromycin lactobionate
エリスロマイシンラクトビオン酸エリスロマイシン

erythromycin」

  [★] エリスロマイシン

WordNet   license wordnet

「an antibiotic (trade name Erythrocin or E-Mycin or Ethril or Ilosone or Pediamycin) obtained from the actinomycete Streptomyces erythreus; effective against many Gram-positive bacteria and some Gram-negative」
Erythrocin, E-Mycin, Ethril, Ilosone, Pediamycin




★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡